Psychedelic Microdosing: A Subreddit Analysis
Toby Lea, Nicole Amada, Henrik Jungaberle
Journal of Psychoactive Drugs October 24, 2019 DOI: 10.1080/02791072.2019.1683260 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Content analysis Peer reviewed |
|---|---|
| Population | Reddit discussions about microdosing |
| Topics | Microdosing |
| Keywords | Pharmacology |
| Citations | 121 |
| Key points | Self-reported benefits of microdosing included cognitive and creative enhancement, reduced depression and anxiety, and improved mood, but limitations included adverse physical effects and concerns about dependence. |
Abstract
Self-administration of very low doses of psychedelic drugs to improve mental health and wellbeing and enhance cognitive function, known as microdosing, has received recent media attention, but little research has been conducted. We conducted a content analysis of discussions about microdosing from the online forum Reddit. We examined motivations, dosing practices, and perceived benefits and limitations of microdosing. Motivations included self-management of mental health issues, improvement of psychosocial wellbeing, and cognitive enhancement. Self-reported benefits included cognitive and creative enhancement, reduced depression and anxiety, enhanced self-insight and mindfulness, improved mood and attitude toward life, improved habits and health behaviors, and improved social interactions and interpersonal connections. Perceived limitations included issues related to dosing, adverse physical effects, taking illegal substances, limited or no mental health or cognitive improvement, increased anxiety, unpleasant "off" days, only short-term benefits, and concerns about dependence and drug-related risks. Standard doses of psychedelic drugs provided in therapeutic settings have potential as novel treatments for some mental health conditions, but clinical research is needed to understand if this is also the case for microdosing. In the meantime, harm reduction resources should be developed and made available to provide the best available information on the safer use of self-administered psychedelics.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Self-reported benefits included cognitive and creative enhancement and reduced depression and anxiety, while limitations included adverse physical effects, increased anxiety, and concerns about dependence.
Synthesized
Citations in the library
Cited by 88
- Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. Journal of Psychopharmacology January 5, 2022
- Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study European Neuropsychopharmacology October 17, 2020
- Microdosing psychedelics: Motivations, subjective effects and harm reduction International Journal of Drug Policy November 25, 2019
- The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955–2021) and recommendations for the field Neuroscience & Biobehavioral Reviews May 21, 2022
- The therapeutic potential of microdosing psychedelics in depression Therapeutic Advances in Psychopharmacology 2020
and 83 more in the library
Cites 18
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases The Journal of Nervous and Mental Disease March 4, 2014
- Potential Therapeutic Effects of Psilocybin. Neurotherapeutics July 1, 2017
and 13 more in the library